Suppr超能文献

用于工程化心脏组织灌注和电刺激的便携式生物反应器。

Portable bioreactor for perfusion and electrical stimulation of engineered cardiac tissue.

作者信息

Tandon Nina, Taubman Alanna, Cimetta Elisa, Saccenti Laetitia, Vunjak-Novakovic Gordana

出版信息

Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:6219-23. doi: 10.1109/EMBC.2013.6610974.

Abstract

Cardiac tissue engineering aims to create functional tissue constructs that can reestablish the structure and function of injured myocardium. Although bioreactors have facilitated the engineering of cardiac patches of clinically relevant size in vitro, a major drawback remains the transportation of the engineered tissues from a production facility to a medical operation facility while maintaining tissue viability and preventing contamination. Furthermore, after implantation, most of the cells are endangered by hypoxic conditions that exist before vascular flow is established. We developed a portable device that provides the perfusion and electrical stimulation necessary to engineer cardiac tissue in vitro, and to transport it to the site where it will be implantated. The micropump-powered perfusion apparatus may additionally function as an extracorporeal active pumping system providing nutrients and oxygen supply to the graft post-implantation. Such a system, through perfusion of oxygenated media and bioactive molecules (e.g. growth factors), could transiently support the tissue construct until it connects to the host vasculature and heart muscle, after which it could be taken away or let biodegrade.

摘要

心脏组织工程旨在创建功能性组织构建体,以重建受损心肌的结构和功能。尽管生物反应器有助于在体外构建具有临床相关尺寸的心脏补片,但一个主要缺点仍然是如何将工程化组织从生产设施运输到医疗手术设施,同时保持组织活力并防止污染。此外,植入后,在建立血管血流之前,大多数细胞会受到缺氧条件的威胁。我们开发了一种便携式设备,该设备可提供在体外构建心脏组织并将其运输到植入部位所需的灌注和电刺激。由微型泵驱动的灌注装置还可以作为体外主动泵系统,在植入后为移植物提供营养和氧气供应。这样的系统通过灌注含氧培养基和生物活性分子(例如生长因子),可以暂时支持组织构建体,直到它与宿主血管和心肌连接,之后可以将其移除或使其生物降解。

相似文献

1
Portable bioreactor for perfusion and electrical stimulation of engineered cardiac tissue.
Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:6219-23. doi: 10.1109/EMBC.2013.6610974.
2
Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue.
J Tissue Eng Regen Med. 2012 Nov;6(10):e12-23. doi: 10.1002/term.525. Epub 2011 Dec 13.
3
Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering.
Tissue Eng Part C Methods. 2010 Dec;16(6):1417-26. doi: 10.1089/ten.TEC.2010.0068. Epub 2010 May 10.
6
Optimization of electrical stimulation parameters for cardiac tissue engineering.
J Tissue Eng Regen Med. 2011 Jun;5(6):e115-25. doi: 10.1002/term.377. Epub 2011 Jan 10.
7
Cardiovascular tissue engineering I. Perfusion bioreactors: a review.
J Long Term Eff Med Implants. 2006;16(2):111-30. doi: 10.1615/jlongtermeffmedimplants.v16.i2.10.
8
A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration.
Tissue Eng. 2006 Oct;12(10):2843-52. doi: 10.1089/ten.2006.12.2843.
10
Analysis of the role of perfusion, mechanical, and electrical stimulation in bioreactors for cardiac tissue engineering.
Bioprocess Biosyst Eng. 2024 Jun;47(6):767-839. doi: 10.1007/s00449-024-03004-5. Epub 2024 Apr 20.

引用本文的文献

1
Advances in 3D Bioprinting: Techniques, Applications, and Future Directions for Cardiac Tissue Engineering.
Bioengineering (Basel). 2023 Jul 16;10(7):842. doi: 10.3390/bioengineering10070842.
2
Microphysiological System for High-Throughput Computer Vision Measurement of Microtissue Contraction.
ACS Sens. 2021 Mar 26;6(3):985-994. doi: 10.1021/acssensors.0c02172. Epub 2021 Mar 3.
3
Current research trends and challenges in tissue engineering for mending broken hearts.
Life Sci. 2019 Jul 15;229:233-250. doi: 10.1016/j.lfs.2019.05.012. Epub 2019 May 17.
4
3D Bioprinting of cardiac tissue and cardiac stem cell therapy.
Transl Res. 2019 Sep;211:64-83. doi: 10.1016/j.trsl.2019.04.004. Epub 2019 Apr 20.
5
Multi-flow channel bioreactor enables real-time monitoring of cellular dynamics in 3D engineered tissue.
Commun Biol. 2019 May 3;2:158. doi: 10.1038/s42003-019-0400-z. eCollection 2019.
6
Strength-duration relationship as a tool to prioritize cardiac tissue properties that govern electrical excitability.
Am J Physiol Heart Circ Physiol. 2019 Jul 1;317(7):H13-H25. doi: 10.1152/ajpheart.00161.2019. Epub 2019 Mar 29.
7
3D printing approaches for cardiac tissue engineering and role of immune modulation in tissue regeneration.
Int J Nanomedicine. 2019 Feb 20;14:1311-1333. doi: 10.2147/IJN.S189587. eCollection 2019.
8
A novel bioreactor for combined magnetic resonance spectroscopy and optical imaging of metabolism in 3D cell cultures.
Magn Reson Med. 2019 May;81(5):3379-3391. doi: 10.1002/mrm.27644. Epub 2019 Jan 16.
9
Fabrication of scaffold-free tubular cardiac constructs using a Bio-3D printer.
PLoS One. 2018 Dec 17;13(12):e0209162. doi: 10.1371/journal.pone.0209162. eCollection 2018.
10
Engineering Scalable Manufacturing of High-Quality Stem Cell-Derived Cardiomyocytes for Cardiac Tissue Repair.
Front Med (Lausanne). 2018 Apr 24;5:110. doi: 10.3389/fmed.2018.00110. eCollection 2018.

本文引用的文献

1
Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue.
J Tissue Eng Regen Med. 2012 Nov;6(10):e12-23. doi: 10.1002/term.525. Epub 2011 Dec 13.
2
Optimization of electrical stimulation parameters for cardiac tissue engineering.
J Tissue Eng Regen Med. 2011 Jun;5(6):e115-25. doi: 10.1002/term.377. Epub 2011 Jan 10.
3
Bioengineering heart muscle: a paradigm for regenerative medicine.
Annu Rev Biomed Eng. 2011 Aug 15;13:245-67. doi: 10.1146/annurev-bioeng-071910-124701.
6
Electrical stimulation systems for cardiac tissue engineering.
Nat Protoc. 2009;4(2):155-73. doi: 10.1038/nprot.2008.183.
7
Cardiac tissue engineering using perfusion bioreactor systems.
Nat Protoc. 2008;3(4):719-38. doi: 10.1038/nprot.2008.40.
8
Analysis of oxygen transport in a diffusion-limited model of engineered heart tissue.
Biotechnol Bioeng. 2007 Jul 1;97(4):962-75. doi: 10.1002/bit.21295.
9
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.
Nat Med. 2006 Apr;12(4):452-8. doi: 10.1038/nm1394. Epub 2006 Apr 2.
10
Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues.
FASEB J. 2006 Apr;20(6):708-10. doi: 10.1096/fj.05-4715fje. Epub 2006 Jan 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验